120 related articles for article (PubMed ID: 11961154)
21. Efficacy of gene therapy for SCID is being confirmed.
Cavazzana-Calvo M; Fischer A
Lancet; 2004 Dec 18-31; 364(9452):2155-6. PubMed ID: 15610783
[No Abstract] [Full Text] [Related]
22. Variant forms of X-linked severe combined immunodeficiency disease: one or many genes?
Disanto JP; Le Deist F; Caniglia M; Markiewicz S; Lebranchu Y; Griscelli C; Fischer A; De Saint-Basile G
Immunodeficiency; 1993; 4(1-4):253-8. PubMed ID: 8167713
[No Abstract] [Full Text] [Related]
23. Leukemia case triggers tighter gene-therapy controls.
Bonetta L
Nat Med; 2002 Nov; 8(11):1189. PubMed ID: 12411927
[No Abstract] [Full Text] [Related]
24. Gene therapy for human SCID: dreams become reality.
Buckley RH
Nat Med; 2000 Jun; 6(6):623-4. PubMed ID: 10835669
[No Abstract] [Full Text] [Related]
25. LMO2 and gene therapy for severe combined immunodeficiency.
Stone BD
N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
[No Abstract] [Full Text] [Related]
26. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.
Flake AW; Roncarolo MG; Puck JM; Almeida-Porada G; Evans MI; Johnson MP; Abella EM; Harrison DD; Zanjani ED
N Engl J Med; 1996 Dec; 335(24):1806-10. PubMed ID: 8943162
[No Abstract] [Full Text] [Related]
27. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
28. Intronic point mutation in the IL2RG gene causing X-linked severe combined immunodeficiency.
Tassara C; Pepper AE; Puck JM
Hum Mol Genet; 1995 Sep; 4(9):1693-5. PubMed ID: 8541866
[No Abstract] [Full Text] [Related]
29. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
[TBL] [Abstract][Full Text] [Related]
30. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
[TBL] [Abstract][Full Text] [Related]
31. Clinical research. Gene therapy a suspect in leukemia-like disease.
Marshall E
Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
[No Abstract] [Full Text] [Related]
32. Successful RAG1-SCID gene therapy depends on the level of RAG1 expression.
Pike-Overzet K; Baum C; Bredius RG; Cavazzana M; Driessen GJ; Fibbe WE; Gaspar HB; Hoeben RC; Lagresle-Peyrou C; Lankester A; Meij P; Schambach A; Thrasher A; Van Dongen JJ; Zwaginga JJ; Staal FJ
J Allergy Clin Immunol; 2014 Jul; 134(1):242-3. PubMed ID: 25117803
[No Abstract] [Full Text] [Related]
33. For gene therapy, now-quantified risks are deemed troubling.
Twombly R
J Natl Cancer Inst; 2003 Jul; 95(14):1032-3. PubMed ID: 12865444
[No Abstract] [Full Text] [Related]
34. Outpatient bone marrow transplantation for severe combined immunodeficiency.
Sorensen RU; Strandjord SE; Coccia PF
Lancet; 1993 Jan; 341(8836):52. PubMed ID: 8093296
[No Abstract] [Full Text] [Related]
35. Treatment fillip for gene therapy ambitions.
Williams N
Curr Biol; 2002 Apr; 12(9):R305-6. PubMed ID: 12007425
[No Abstract] [Full Text] [Related]
36. Addendum to SCID, interleukin-2, and the interleukin-2 receptor review.
Sondel PM; Voss SD; Hong R
Blood; 1994 Jul; 84(2):667-8. PubMed ID: 8025293
[No Abstract] [Full Text] [Related]
37. Acute monocytic leukemia in a dog with X-linked severe combined immunodeficiency.
Felsburg PJ; Somberg RL; Krakowka GS
Clin Diagn Lab Immunol; 1994 Jul; 1(4):379-84. PubMed ID: 8556472
[TBL] [Abstract][Full Text] [Related]
38. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
Puck JM; Pepper AE; Bédard PM; Laframboise R
J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
[TBL] [Abstract][Full Text] [Related]
39. Retroviral-mediated transfer and expression of the common gamma chain into human hematopoietic progenitors.
Candotti F; Onodera M; Knazek RA; Blaese RM
Acta Haematol; 1999; 101(2):106-10. PubMed ID: 10202241
[TBL] [Abstract][Full Text] [Related]
40. [X-linked severe combined immunodeficiency].
Kumaki S
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):140-5. PubMed ID: 11963175
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
